Assignee
VIR BIOTECHNOLOGY INC
US·7 granted patents·27 pending applications·19 citations·filing 2015–2025
Top patents by PatentIndex Score
34 records- 0194US11168128B2Antibodies against SARS-CoV-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Granted Nov 9, 2021·12 cites·30 claims
- 0291US11479599B2Antibodies against SARS-CoV-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Granted Oct 25, 2022·2 cites·30 claims
- 0389US10894078B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2015·Granted Jan 19, 2021·4 cites·26 claims
- 0471US11628215B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2020·Granted Apr 18, 2023·0 cites·7 claims
- 0571US11554168B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2020·Granted Jan 17, 2023·0 cites·24 claims
- 0671US2023331821A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 0767US2024382474A1Enpp1 modulators and uses thereofVIR BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 0864US12404318B2Combination HBV therapyVIR BIOTECHNOLOGY INC·Filed 2019·Granted Sep 2, 2025·1 cites·16 claims
- 0963US2024371528A1Machine learning for predicting mutational drivers and likely onset of future pandemicsVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1062US12485168B2Hepatitis B virus vaccinesVIR BIOTECHNOLOGY INC·Filed 2020·Granted Dec 2, 2025·0 cites·15 claims
- 1162US2023183188A1Enpp1 modulators and uses thereofVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1262US2026022161A1Combination hbv therapyVIR BIOTECHNOLOGY INC·Filed 2025·Application pending·0 cites
- 1361US2025041399A1Cmv-based human papillomavirus vaccinesVIR BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 1458US2023210879A1Treatment of respiratory virus infection by modulation of the n-glycosylation pathwayVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1557US2024384296A1Recombinant hcmv vectors and uses thereofVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1656US2025296986A1Engineered polypeptidesVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1755US2025136949A1Methods for producing cmv vectorsVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1855US2024350607A1Tuberculosis vaccinesVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1955US2025320497A1Compositions and methods for treating hepatitis b virus (hbv) infection and hbv-associated diseasesVIR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 2053US2023242621A1Engineered hepatitis b virus neutralizing antibodies and uses thereofVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2152US2024400652A1Antibody therapies for sars-cov-2 infection in pediatric subjectsVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 2252US2023282305A1Predictive Universal Signatures for Multiple Disease IndicationsVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2352US2025302951A1Compositions and methods for treating hepatitis d virus (hdv) infection and associated diseasesVIR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 2452US2024317841A1Antibodies against influenza a virusesVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2551US2025263466A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2650US2024141021A1Anti-influenza antibodies and combinations thereofVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2750US2024092876A1Broadly neutralizing antibodies against influenza neuraminidaseVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2850US2024059757A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2949US2023340083A1Antibodies and methods for treatment of influenza a infectionVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3047US2025263467A1Antibody therapies for sars-cov-2 infectionVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3144US2024092872A1Compositions and methods for treating hepatitis b virus infectionVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 3243US2022306728A1Compositions and methods for treatment of influenza a infectionVIR BIOTECHNOLOGY INC·Filed 2020·Application pending·0 cites
- 3343US2022380441A1Antibody compositions and methods for treating hepatitis b virus infectionVIR BIOTECHNOLOGY INC·Filed 2020·Application pending·0 cites
- 3432US2022339256A1Compositions and methods for treating hepatitis b virus (hbv) infectionVIR BIOTECHNOLOGY INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VIR BIOTECHNOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →